Literature DB >> 34731558

VITT after ChAdOx1 nCoV-19 Vaccination. Reply.

Marie Scully1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34731558     DOI： 10.1056/NEJMc2111026

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

Review 2.  [The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 1: recommendations].

Authors:  Tobias Monschein; Tobias Zrzavy; Micha Löbermann; Alexander Winkelmann; Thomas Berger; Paulus Rommer; Hans-Peter Hartung; Uwe K Zettl
Journal:  Nervenarzt       Date:  2021-07-07       Impact factor: 1.297

3.  Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.

Authors:  Elsa V C Rodriguez; Fatima-Zohra Bouazza; Nicolas Dauby; François Mullier; Stéphanie d'Otreppe; Patrice Jissendi Tchofo; Magali Bartiaux; Camille Sirjacques; Alain Roman; Cédric Hermans; Manuel Cliquennois
Journal:  Infection       Date:  2021-10-09       Impact factor: 7.455

Review 4.  A systematic review of vaccine-induced thrombotic thrombocytopenia in individuals who received COVID-19 adenoviral-vector-based vaccines.

Authors:  Mostafa H Elberry; Hussien Ahmed H Abdelgawad; Aboalmagd Hamdallah; Walid Shaban Abdella; Ahmed Sayed Ahmed; Hazem S Ghaith; Ahmed Negida
Journal:  J Thromb Thrombolysis       Date:  2022-02-14       Impact factor: 5.221
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.